Marcy Bolster to Treatment Outcome
This is a "connection" page, showing publications Marcy Bolster has written about Treatment Outcome.
Connection Strength
0.169
-
Current approaches to osteoporosis treatment. Curr Opin Rheumatol. 2015 May; 27(3):216-24.
Score: 0.056
-
Pulmonary Hemosiderosis with Calcification Associated with IgA Nephropathy. Am J Respir Crit Care Med. 2021 07 15; 204(2):e24-e25.
Score: 0.022
-
A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritis. Rheumatology (Oxford). 2020 07 01; 59(7):1505-1513.
Score: 0.020
-
Using electronic visits (E-visits) to achieve goal serum urate levels in patients with gout in a rheumatology practice: A pilot study. Semin Arthritis Rheum. 2020 12; 50(6):1382-1386.
Score: 0.020
-
Effects of Teriparatide on Joint Erosions in Rheumatoid Arthritis: A Randomized Controlled Trial. Arthritis Rheumatol. 2017 09; 69(9):1741-1750.
Score: 0.016
-
Insufficiency fracture associated with oncogenic osteomalacia. J Clin Rheumatol. 2013 Jan; 19(1):38-42.
Score: 0.012
-
Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. Am J Respir Crit Care Med. 2007 Nov 15; 176(10):1026-34.
Score: 0.008
-
Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study. Arthritis Rheum. 2007 May; 56(5):1676-84.
Score: 0.008
-
Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med. 2006 Jun 22; 354(25):2655-66.
Score: 0.008